Frankfurt
25.08.26 | 08:03
0,000 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,011 | 0,031 | 10:33 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.08. | KDventures AB: KDventures' portfolio company Umecrine Cognition enrolls last patient in ongoing Phase 1b/2a study | 128 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, August 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company Umecrine Cognition has enrolled the last patient in the ongoing Phase 1b/2a study... ► Artikel lesen | |
| 12.05. | KDventures AB: KDventures' Annual General Meeting 2026 | 253 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - May 12, 2026. KDventures AB (publ) ("KDventures" or the "Company") held the Annual General Meeting on May 12, 2026. The shareholders have had the right to exercise their voting rights... ► Artikel lesen | |
| 30.04. | KDventures AB: Interim Report - January-March 2026 | 254 | GlobeNewswire (Europe) | STOCKHOLM - 30 April 2026. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Interim Report January-March 2026. The full report is available on the Company's website.
"We started 2026 by strengthening... ► Artikel lesen | |
| 09.04. | KDventures AB: KDventures' portfolio company SVF Vaccines partners with Touchlight to accelerate SVF-001 toward clinical development | 242 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, April 9, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company SVF Vaccines has entered into a collaboration with Touchlight, a biotechnology company... ► Artikel lesen | |
| 11.03. | KDventures AB: KDventures' portfolio company AnaCardio extends IP protection for AC01 until the 2040s with new US patent approval | 262 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN March 11, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company AnaCardio has received approval for a US patent covering the use of AC01 for the treatment... ► Artikel lesen | |
| KDVENTURES Aktie jetzt für 0€ handeln | |||||
| 03.03. | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | 458 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| 27.02. | Change of number of shares and votes in KDventures AB | 1 | GlobeNewswire (USA) | ||
| 24.02. | KDventures AB: KDventures's portfolio company SVF Vaccines announces that the intended merger with Novakand Pharma will not be carried out following negative decision from Nasdaq | 464 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be completed... ► Artikel lesen | |
| 13.02. | KDventures AB: Year-end Report - January-December 2025 | 319 | GlobeNewswire (Europe) | STOCKHOLM - 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report January-December 2025. The full report is available on the Company's website. "A stronger financial... ► Artikel lesen | |
| 12.02. | KDventures AB (publ): KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue | 355 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 10.02. | KDventures AB (publ): KDventures' portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer | 384 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 10 February 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that its portfolio company SVF Vaccines has appointed Raheleh Nassaji as Chief Executive Officer to lead the transition... ► Artikel lesen | |
| 09.02. | Change of issuer name and symbol for Karolinska Development AB | 421 | GlobeNewswire | As from February 10, 2026, Karolinska Development AB will change issuer name and symbol.
Old issuer name: Karolinska Development AB
New issuer name: KDventures AB
Old symbol: KDEV
New symbol: KDV
ISIN... ► Artikel lesen | |
| 06.02. | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement | 340 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand... ► Artikel lesen | |
| 28.01. | Karolinska Development AB: Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB | 449 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 23.01. | Karolinska Development AB (publ): Karolinska Development AB receives additional guarantee commitments in ongoing rights issue | 721 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 21.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin | 314 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's... ► Artikel lesen | |
| 12.01. | Listing of subscription rights and paid subscription shares of Karolinska Development AB | 414 | GlobeNewswire | With effect from January 13, 2026, the subscription rights of Karolinska Development AB will be traded on the list for Equity rights. Trading will continue up until and including January 22, 2026.
... ► Artikel lesen | |
| 09.01. | Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue | 346 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 08.01. | Karolinska Development AB (publ): Karolinska Development's Extraordinary General Meeting 2026 | 468 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 8, 2026. Karolinska Development AB (publ) ("Karolinska Development" or the "Company") held an Extraordinary General Meeting on January 8, 2026, at which the shareholders... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 839 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NAKIKI | 0,161 | -11,33 % | Nakiki SE: Wirtschaftsprüfer versagt für 2024 das Testat | Der Abschlussprüfer der Nakiki SE hat dem Jahresabschluss und Lagebericht für das Rumpfgeschäftsjahr vom 3. April bis 31. Dezember 2024 das Testat versagt. Grund ist nach Angaben der Gesellschaft, dass... ► Artikel lesen | |
| ISHARES BITCOIN TRUST | 44,625 | -0,03 % | Krypto-Rallye hat Nebeneffekt: Bitcoin-ETFs verbuchen stärkste Wochenzuflüsse seit zehn Monaten | © Foto: Dall-EBitcoin-ETFs ziehen im Zuge der Krypto-Rallye wieder deutlich mehr Anlegerkapital an. Auch Ethereum-ETFs verzeichnen die höchsten Zuflüsse seit Oktober Enthaltene Werte: BTC~USD,ETH~USD... ► Artikel lesen | |
| DIREXION DAILY SEMICONDUCTOR BEAR 3X | 50,71 | 0,00 % | SOXL Tumbles As Micron, SanDisk Drag Semis Lower; SOXS Spikes On Memory Shockwave | ||
| CHIME FINANCIAL | 32,720 | +0,06 % | Knowlej and Chime Launch Financial Futures Campaign to Help Students Build Financial Confidence and Strengthen Engagement in School | LOS ANGELES, April 17, 2026 /PRNewswire/ -- Knowlej today announced the launch of Knowlej Financial Futures, powered by leading financial technology company Chime, a new financial literacy... ► Artikel lesen | |
| REMITLY GLOBAL | 26,590 | 0,00 % | NIGEL MORRIS Implements A Sell Strategy: Offloads $611K In Remitly Global Stock | ||
| FIDELITY WISE ORIGIN BITCOIN FUND | 68,56 | 0,00 % | Fidelity zieht 46,8 Mio. US-Dollar aus dem FBTC ab, da Bitcoin-ETFs ins Minus rutschen | ||
| DIREXION DAILY S&P 500 BULL 3X | 284,07 | 0,00 % | Direxion Daily S&P 500 Bull 3X Shares declares quarterly distribution of $0.5231 | ||
| ALLIANZ | 448,10 | +0,61 % | Allianz: Gefährlich teuer? Die Bewertung im Realitätscheck | Die Allianz-Aktie kennt derzeit kaum ein Halten. Seit Anfang Juni befindet sie sich im Höhenflug. Seit Wochen folgt ein Rekordhoch nach dem nächsten. Damit rückt allerdings eine Frage in den Vordergrund:... ► Artikel lesen | |
| PROSHARES ULTRA QQQ | 87,72 | 0,00 % | $1000 Invested In ProShares Ultra QQQ 10 Years Ago Would Be Worth This Much Today | ||
| REAL ESTATE SELECT SECTOR SPDR FUND | 45,345 | 0,00 % | XLRE reaches 52-week high after upbeat housing data; here are its top holdings | ||
| GRAYSCALE ETHEREUM STAKING MINI | 23,590 | 0,00 % | Doch sicherer Hafen?: Bitcoin bleibt stabil trotz ETF-Abflüssen und Nahost-Sorgen | © Foto: Dall-EBitcoin überrascht entgegen allen Erwartungen und behauptet sich, obwohl ETF-Abflüsse, die Nahost-Eskalation und eine restriktive Fed für Unsicherheit sorgen.Der Kryptomarkt präsentiert... ► Artikel lesen | |
| DEUTSCHE BANK | 33,120 | +0,20 % | Deutsche Bank Aktie: Vor einer wichtigen Hürde | Die Aktie der Deutschen Bank hat die jüngste Konsolidierung gestern fortgesetzt und 1% auf 33,07 EUR abgegeben. Rückblick: Nach dem Rücksetzer an die 200-Tage-Linie in der vorletzten Juliwoche war es... ► Artikel lesen | |
| SPROTT PHYSICAL GOLD TRUST | 35,320 | 0,00 % | Sprott Physical Gold Trust USD reports Q2 results | ||
| GRAYSCALE ETHEREUM STAKING | 19,910 | 0,00 % | Grayscale Ethereum Staking ETF - 10-Q, Quarterly Report | ||
| ROCKET COMPANIES | 14,105 | +0,07 % | Rocket Companies Swings To Profit In Q2 | WASHINGTON (dpa-AFX) - Rocket Companies (RKT) on Thursday reported second-quarter net revenue of $2.78 billion, up from $1.45 billion in the year-ago quarter.Net income attributable to Rocket... ► Artikel lesen |
KDVENTURES AB gehört der Branche Finanzdienstleistungen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KDVENTURES AB finden Sie auf Wallstreet Online.